While we gather around the table on Thursday, many of us will give thanks for the blessings in our lives. Will workers’ comp be among them? In this edition of Inside Workers’ Comp, we asked industry experts Chikita Mann, Mark
More stories
Workers' Comp
White Paper
From Hospital to Home and All Points in Between: The Importance of Transition of Care Planning in Driving The Best Possible Outcomes
Discover the transformative power of transition of care planning for your toughest claims in our latest white paper, From Hospital to Home and All Points In Between: The Importance of Transition of Care Planning.
Workers' Comp
Article
Six Legislative and Regulatory Changes and Trends Impacting the Insurance Industry
Explore the critical legislative and regulatory changes impacting the insurance industry in 2024. Stay informed on AAPAN's role, CMS updates, and trends in auto and workers' compensation.
Workers' Comp
Article
Enlyte Lobbying Outlooks for 2024
At Enlyte, our team of experts are continually monitoring emerging trends, keeping abreast with legislation and case law, and lobbying to help shape these complexities today and into tomorrow for the benefit of our customers and the industry.
Workers' Comp
Article
Specialty Solutions Spotlight: Cybersecurity Risks With Internet Connected Medical Devices
The advent of the Internet of Medical Things (IoMT) has facilitated the transmission of data from medical devices and enabled physicians to remotely customize treatment settings. However, like other computer systems, medical devices are susceptible to security breaches, which have the potential to compromise the device’s safety and effectiveness.
Workers' Comp
Article
Ask The Pharmacist: Fixed-Dose Combination Drugs in Workers’ Comp
Fixed-dose combination drug products (FDCDPs) are made up of two different drug ingredients in a single formulation, containing a fixed amount of each. Among the more recognizable examples of these are Symbicort (budesonide-formoterol), Suboxone (buprenorphine-naloxone), Treximet (sumatriptan-naproxen), and Tylenol PM (acetaminophen-diphenhydramine). Several FDCDPs for pain management also exist such as Vimovo (naproxen-esomeprazole), Duexis (ibuprofen-famotidine), and Seglentis (celecoxib-tramadol).
Workers' Comp
News Release
Enlyte’s 2024 Trends Report Addresses Top Challenges in the P&C Industry
As the Property and Casualty industry sets course for 2024, executives face continuing challenges in integrating generative AI, understanding data analytics maturity, staying current with prescription drug trends, and managing medical and auto claims costs amidst fears of inflation and legislative and regulatory changes.